Stock SEZI SENZIME AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Senzime AB

Equities

SEZI

SE0002478776

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:54 2024-05-28 am EDT 		5-day change 1st Jan Change
6.58 SEK +4.44% Intraday chart for Senzime AB -0.45% -11.44%
May. 21 New Clinical Study Published in Anesthesiology Confirms the Leading Accuracy and Precision of Senzime's TetraGraph System CI
May. 07 Transcript : Senzime AB, Q1 2024 Earnings Call, May 07, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 954.6 1,500 1,425 750.6 889.4 787.7 - -
Enterprise Value (EV) 1 923.7 1,500 1,350 737.6 749.9 751.7 787.7 764.7
P/E ratio -26.8 x -28.6 x -17.4 x -5.4 x -5.12 x -7.65 x -19.9 x 27.4 x
Yield - - - - - - - -
Capitalization / Revenue 142 x - 130 x 53.5 x 24.9 x 10.7 x 4.38 x 2.45 x
EV / Revenue 138 x - 123 x 52.6 x 21 x 10.2 x 4.38 x 2.38 x
EV / EBITDA -38.5 x - -18.4 x -6.23 x -6.42 x -8.79 x -39.2 x 13.6 x
EV / FCF -29.8 x - - - -6.16 x -7.52 x -27.2 x 27.3 x
FCF Yield -3.35% - - - -16.2% -13.3% -3.68% 3.66%
Price to Book 5.53 x - 11.9 x 2.87 x 1.83 x 2.84 x 3.31 x 2.95 x
Nbr of stocks (in thousands) 52,448 62,493 62,493 69,884 119,706 119,706 - -
Reference price 2 18.20 24.00 22.80 10.74 7.430 6.580 6.580 6.580
Announcement Date 2/14/20 2/26/21 2/17/22 2/1/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6.711 - 10.98 14.03 35.75 73.8 179.8 321.8
EBITDA 1 -23.97 - -73.2 -118.4 -116.8 -85.5 -20.1 56.1
EBIT 1 -36.43 - -84.19 -133.9 -137.4 -107 -42 30
Operating Margin -542.86% - -766.77% -954.15% -384.18% -144.99% -23.36% 9.32%
Earnings before Tax (EBT) 1 -36.43 - -84.29 -134.4 -137.2 -105 -41 30
Net income 1 -33.68 -47.44 -82.14 -132.7 -141 -103 -40 29
Net margin -501.8% - -748.11% -945.56% -394.35% -139.57% -22.25% 9.01%
EPS 2 -0.6800 -0.8400 -1.310 -1.990 -1.450 -0.8600 -0.3300 0.2400
Free Cash Flow 1 -30.97 - - - -121.7 -100 -29 28
FCF margin -461.51% - - - -340.46% -135.5% -16.13% 8.7%
FCF Conversion (EBITDA) - - - - - - - 49.91%
FCF Conversion (Net income) - - - - - - - 96.55%
Dividend per Share - - - - - - - -
Announcement Date 2/14/20 2/26/21 2/17/22 2/1/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 7.288 8.462 9.154 10.85 12.12 16.8 19.7 25.2
EBITDA 1 -26.46 -30.2 -25.48 -34.66 -23.91 -23.4 -19.3 -18.9
EBIT 1 -31.42 -35.26 -30.59 -40.09 -29.34 -28.8 -24.7 -24.3
Operating Margin -431.16% -416.65% -334.21% -369.46% -242.04% -171.43% -125.38% -96.43%
Earnings before Tax (EBT) 1 -31.69 -35.26 -30.59 -39.62 -28.72 -28.4 -24.3 -24
Net income 1 -30.8 -34.36 -30.17 -38.81 -27.93 -27.7 -23.7 -23.5
Net margin -422.65% -406.1% -329.63% -357.68% -230.44% -164.88% -120.3% -93.25%
EPS 2 - -0.4200 -0.3300 -0.3300 -0.2300 -0.2000 -0.2000 -0.2000
Dividend per Share - - - - - - - -
Announcement Date 4/28/23 8/24/23 10/26/23 2/15/24 5/7/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 30.9 - 74.9 13 140 36 - 23
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -31 - - - -122 -100 -29 28
ROE (net income / shareholders' equity) -20.3% - -53.1% -64.3% - - - 11%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 3.290 - 1.910 3.750 4.070 2.320 1.990 2.230
Cash Flow per Share -0.5500 - - - - - - -
Capex 1 3.77 - - - 0.95 2 2 2
Capex / Sales 56.12% - - - 2.66% 2.71% 1.11% 0.62%
Announcement Date 2/14/20 2/26/21 2/17/22 2/1/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Senzime AB

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SENZIME AB Stock Senzime AB
-11.44% 74.69M
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.38% 177B
MEDTRONIC PLC Stock Medtronic plc
-0.46% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.98% 65.55B
DEXCOM, INC. Stock DexCom, Inc.
+2.65% 50.66B
CENCORA, INC. Stock Cencora, Inc.
+5.27% 42.58B
HOYA CORPORATION Stock Hoya Corporation
+6.01% 40.74B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+19.92% 31.07B
TERUMO CORPORATION Stock Terumo Corporation
+16.21% 25.45B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-7.00% 23.85B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. SEZI Stock
  4. Financials Senzime AB